Business and Finance

So-called ‘off the shelf’ CAR-T treatments could change the field just as first products enter commercialization

Existing ‘pay for performance’ models do not scale up well yet

Forecast is for 3-6% CAGR through 2022

$67-billion Cigna bid, if permitted, would pull in the last large independent PBM

Financial analysis shows PBMs’ greater conversion of profits to earnings

Dohmen Life Sciences Services is joined to a trio of recent acquisitions

Rite Aid brand will be expanded to include Albertsons’ pharmacies

Merger of two giants in their respective fields has global implications

New software solutions and an updated Revenue Cloud for Pharma

Most proposed solutions are already in the works

Another attempt by payers to control their healthcare costs; possible broader implications

Deal brings Celgene into the CAR-T arena

Acquired company lasted less than a year after Biogen spinoff

HDA 2017-8 Factbook details rising wholesaler involvement

Acquisition brings retail pharmacy and PBM together with a health insurer

Private equity firm acquires UBC

The Netherlands wins out in the competition to move the agency from London

$815-million deal to close in early 2018

Rumors of a $60-billion acquisition shake up healthcare services landscape—and what about Amazon?

New identity stresses ‘human data science’

Revised deal brings 1,932 stores to Walgreens Boots Alliance

Bloomington, IN, facility is the prize

‘An unaffordable drug is 100 percent ineffective’

First gene therapy product in US; approval expedited by evidence of high cure rates

Investors hope for a repeat of Gilead’s Sovaldi success

Observers are critical of the $465-million penalty as too lenient

Leading CRO looks to better trial recruitment, outcomes research